First Allied Advisory Services’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $1.09M | Sell |
1,939
-1,261
| -39% | -$706K | 0.04% | 451 |
|
|
2020
Q2 | $2M | Buy |
3,200
+1,259
| +65% | +$785K | 0.07% | 271 |
|
|
2020
Q1 | $948K | Sell |
1,941
-66
| -3% | -$32.2K | 0.04% | 402 |
|
|
2019
Q4 | $758K | Sell |
2,007
-1,082
| -35% | -$409K | 0.03% | 573 |
|
|
2019
Q3 | $853K | Sell |
3,089
-555
| -15% | -$153K | 0.03% | 509 |
|
|
2019
Q2 | $1.14M | Sell |
3,644
-5
| -0.1% | -$1.57K | 0.04% | 427 |
|
|
2019
Q1 | $1.49M | Buy |
3,649
+74
| +2% | +$30.2K | 0.05% | 357 |
|
|
2018
Q4 | $1.33M | Buy |
3,575
+501
| +16% | +$186K | 0.05% | 350 |
|
|
2018
Q3 | $1.24M | Buy |
3,074
+424
| +16% | +$171K | 0.04% | 411 |
|
|
2018
Q2 | $913K | Buy |
2,650
+415
| +19% | +$143K | 0.03% | 482 |
|
|
2018
Q1 | $767K | Buy |
2,235
+27
| +1% | +$9.27K | 0.03% | 528 |
|
|
2017
Q4 | $835K | Buy |
2,208
+354
| +19% | +$134K | 0.03% | 497 |
|
|
2017
Q3 | $827K | Buy |
1,854
+226
| +14% | +$101K | 0.04% | 467 |
|
|
2017
Q2 | $797K | Sell |
1,628
-40
| -2% | -$19.6K | 0.04% | 483 |
|
|
2017
Q1 | $646K | Buy |
1,668
+53
| +3% | +$20.5K | 0.03% | 503 |
|
|
2016
Q4 | $593K | Buy |
1,615
+119
| +8% | +$43.7K | 0.03% | 530 |
|
|
2016
Q3 | $601K | Buy |
1,496
+90
| +6% | +$36.2K | 0.03% | 506 |
|
|
2016
Q2 | $487K | Buy |
1,406
+60
| +4% | +$20.8K | 0.03% | 560 |
|
|
2016
Q1 | $485K | Sell |
1,346
-815
| -38% | -$294K | 0.03% | 548 |
|
|
2015
Q4 | $1.17M | Buy |
2,161
+89
| +4% | +$48.3K | 0.06% | 328 |
|
|
2015
Q3 | $962K | Sell |
2,072
-71
| -3% | -$33K | 0.05% | 357 |
|
|
2015
Q2 | $1.1M | Sell |
2,143
-158
| -7% | -$81.3K | 0.05% | 373 |
|
|
2015
Q1 | $1.03M | Sell |
2,301
-180
| -7% | -$80.7K | 0.07% | 343 |
|
|
2014
Q4 | $1.02M | Sell |
2,481
-1,236
| -33% | -$506K | 0.07% | 317 |
|
|
2014
Q3 | $1.35M | Buy |
3,717
+720
| +24% | +$261K | 0.11% | 227 |
|
|
2014
Q2 | $846K | Sell |
2,997
-257
| -8% | -$72.5K | 0.06% | 368 |
|
|
2014
Q1 | $977K | Buy |
3,254
+2,304
| +243% | +$692K | 0.07% | 305 |
|
|
2013
Q4 | $261K | Sell |
950
-1,838
| -66% | -$505K | 0.02% | 726 |
|
|
2013
Q3 | $871K | Buy |
+2,788
| New | +$871K | 0.05% | 344 |
|